These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7343249)

  • 41. Immune response in mice infected with the attenuated Japanese encephalitis vaccine strain SA14-14-2.
    Lee T; Komiya T; Watanabe K; Aizawa C; Hashimoto H
    Acta Virol; 1995 Jun; 39(3):161-4. PubMed ID: 8578998
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vaccine schedules and procedures.
    Middleton DB; Zimmerman RK; Mitchell KB
    J Fam Pract; 2005 Jan; 54(1 Suppl):S37-50. PubMed ID: 15623393
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [A special immunization clinic tailors vaccinations].
    Aronsson B; Blennow M
    Lakartidningen; 2008 May 28-Jun 3; 105(22):1675-9. PubMed ID: 18590010
    [No Abstract]   [Full Text] [Related]  

  • 44. Preparation and characterization of Japanese encephalitis virus vaccine loaded poly(L-lactide-co-glycolide) microspheres for oral immunization.
    Khang G; Cho JC; Lee JW; Rhee JM; Lee HB
    Biomed Mater Eng; 1999; 9(1):49-59. PubMed ID: 10436853
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Seroepidemiology of Japanese encephalitis viral infection among 3-6 years old children from mountainous and plains townships located in the northern, central, southern and eastern Taiwan].
    Hsu LC; Wu YC; Lin SR; King CC; Ho MS; Lu CF; Hsu HM; Chen KT; Horng CB
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1997 Aug; 30(3):194-206. PubMed ID: 10592824
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of the potency of BIKEN inactivated Japanese Encephalitis vaccine and DNA vaccines in an intracerebral Japanese Encephalitis virus challenge.
    Ashok MS; Rangarajan PN
    Vaccine; 2000 Sep; 19(2-3):155-7. PubMed ID: 11032563
    [No Abstract]   [Full Text] [Related]  

  • 47. Immunological equivalence between mouse brain-derived and Vero cell-derived Japanese encephalitis vaccines.
    Abe M; Shiosaki K; Hammar L; Sonoda K; Xing L; Kuzuhara S; Kino Y; Holland Cheng R
    Virus Res; 2006 Nov; 121(2):152-60. PubMed ID: 16815584
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tick-borne encephalitis (TBE) vaccination: applying the most suitable vaccination schedule.
    Schöndorf I; Beran J; Cizkova D; Lesna V; Banzhoff A; Zent O
    Vaccine; 2007 Feb; 25(8):1470-5. PubMed ID: 17196713
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A field trial with an improved Japanese encephalitis vaccine in a nonendemic area of the disease.
    Kanamitsu M; Hashimoto N; Urasawa S; Katsurada M; Kimura H
    Biken J; 1970 Dec; 13(4):313-28. PubMed ID: 5510351
    [No Abstract]   [Full Text] [Related]  

  • 50. Should travellers to Asia be vaccinated against Japanese encephalitis?
    Denning DW; Kaneko Y
    Lancet; 1987 Apr; 1(8537):853-4. PubMed ID: 2882247
    [No Abstract]   [Full Text] [Related]  

  • 51. Selection of immunodominant fragments from envelope gene for vaccine against Japanese encephalitis virus in DNA priming-protein boosting protocols.
    Chen CT; Yi YC; Chiang SC; Liu KC; Lin YL; Lee ST
    Microb Pathog; 2005; 38(2-3):53-62. PubMed ID: 15748807
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of murine bone marrow-derived dendritic cells loaded with inactivated virus as a vaccine against Japanese encephalitis virus.
    Li Y; Xu M; Chen L; Zhu J; Ye J; Liu X; Sun Y; Chen H; Cao S
    Vaccine; 2009 Oct; 27(43):6004-10. PubMed ID: 19665607
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Vaccinations in childhood: when and why].
    Ugazio AG; Plebani A
    Recenti Prog Med; 1993 Dec; 84(12):864-72. PubMed ID: 8108602
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of Japanese encephalitis virus DNA vaccine candidates in rhesus monkeys [Macaca mulatta].
    Bharati K; Rani R; Vrati S
    Vaccine; 2009 Jan; 27(1):10-6. PubMed ID: 18996161
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systemic immediate-type reactions to gelatin included in Japanese encephalitis vaccines.
    Sakaguchi M; Yoshida M; Kuroda W; Harayama O; Matsunaga Y; Inouye S
    Vaccine; 1997 Feb; 15(2):121-2. PubMed ID: 9066026
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Japanese encephalitis: report of a World Health Organization Working Group.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1984 Mar; 33(9):119-20, 125. PubMed ID: 6321941
    [No Abstract]   [Full Text] [Related]  

  • 57. Short-term safety of live attenuated Japanese encephalitis vaccine (SA14-14-2): results of a randomized trial with 26,239 subjects.
    Liu ZL; Hennessy S; Strom BL; Tsai TF; Wan CM; Tang SC; Xiang CF; Bilker WB; Pan XP; Yao YJ; Xu ZW; Halstead SB
    J Infect Dis; 1997 Nov; 176(5):1366-9. PubMed ID: 9359740
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States. The VAERS Working Group.
    Takahashi H; Pool V; Tsai TF; Chen RT
    Vaccine; 2000 Jul; 18(26):2963-9. PubMed ID: 10825597
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Vaccination: strategies].
    Partouche S; Planquois MC; Rousseau A
    Soins Gynecol Obstet Pueric Pediatr; 1983 May; (24):33-7. PubMed ID: 6554930
    [No Abstract]   [Full Text] [Related]  

  • 60. [Comparison of plaque reduction and active mouse protection tests for estimating the potency of Japanese encephalitis vaccine].
    Chou FY; Chang SN; Lu CH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1986 Aug; 19(3):197-202. PubMed ID: 3816364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.